Status: Recruiting
HUC-MSC for Treatment of High-risk HPV Infection
To evaluate the safety and initial effectiveness of human umbilical cord mesenchymal stem cells in HPV clearance.
Participants needed: 60
Trial details
Phase: Phase 1, Phase 2Age: 25-60Biological sex: FemaleType: InterventionalSponsor: Shanghai East HospitalUpdated: Sep 24, 2024Locations: 1
Eligibility criteria
Women aged 25-60 with a sexual history of more than 2 years; [+4]
Women who are preparing for pregnancy, pregnancy or breastfeeding; [+9]